2.690EUR0.00%Mkt Cap: 239.98M $P/E: 53.801d ago
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
P/B
Cheaper
Div Yield
Higher
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap239.98M $
Enterprise Value329.33M $
Revenue (TTM)364.14M $
Gross Profit212.88M $
Net Income (TTM)5.46M $
Revenue/Share4.473 USD
Last Price2.690 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0165359029
Valuation
P/E (Trailing)53.80
P/E (Forward)22.42
PEG0.34
EV/EBITDA13.33
EV/Revenue0.90
P/S0.66
P/B0.99
EPS (TTM)0.05
EPS (Forward)0.12
52W Range
2.32036% of range3.350
52W High3.350 EUR
52W Low2.320 EUR
Profitability
Gross Margin59.15%
Oper. Margin4.03%
EBITDA Margin6.79%
Profit Margin1.52%
ROE2.30%
ROA1.27%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.65M $
CapEx (TTM)19.90M $
FCF Margin—
FCF Yield—
Net Debt88.79M $
Net Debt/EBITDA3.59
Balance Sheet
Debt/Equity0.42
Current Ratio1.55
Quick Ratio0.87
Book Value/Sh2.718 EUR
Cash/Share0.2650 EUR
Dividends
Fwd Div Rate0.0200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.90%
5Y Avg Yield1.52%
Payout Ratio94.59%
Ex-Div DateMay 21, 2026
Pay Date—
Splits
Last Split1:20
Split DateSep 22, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.82.08M
Float21.47M
Insiders79.09%
Institutions6.96%
Technical
SMA 502.715 (-0.9%)
SMA 2002.715 (-0.9%)
Beta0.95
S&P 52W Chg20.05%
Avg Vol (30d)6.03K
Avg Vol (10d)4.28K
Technical Indicators
RSI (14)49.1
MACD-0.0040
MACD Signal-0.0048
MACD Hist.+0.0008
BB Upper2.732 EUR
BB Middle2.691 EUR
BB Lower2.650 EUR
BB Width3.08%
ATR (14)0.0355 EUR
Vol Ratio (20d)0.21x